Cas:20680-06-2 3-(4-hydroxyphenyl)-1-methoxy-1-methylurea manufacturer & supplier

We serve Chemical Name:3-(4-hydroxyphenyl)-1-methoxy-1-methylurea CAS:20680-06-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

3-(4-hydroxyphenyl)-1-methoxy-1-methylurea

Chemical Name:3-(4-hydroxyphenyl)-1-methoxy-1-methylurea
CAS.NO:20680-06-2
Synonyms:N’-4-hydroxyphenyl-N-methoxy-N-methylurea
Molecular Formula:C9H12N2O3
Molecular Weight:196.20300
HS Code:2924299090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:61.80000
Exact Mass:196.08500
LogP:1.49030

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like N’-4-hydroxyphenyl-N-methoxy-N-methylurea chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,N’-4-hydroxyphenyl-N-methoxy-N-methylurea physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,N’-4-hydroxyphenyl-N-methoxy-N-methylurea Use and application,N’-4-hydroxyphenyl-N-methoxy-N-methylurea technical grade,usp/ep/jp grade.


Related News: Lonza is investing CHF 20 million in GMP laboratories and mid-scale manufacturing assets at its API manufacturing center in Nansha, China. The investment will allow Lonza to provide a smoother transition from small-scale to large-scale manufacturing for customers. 2-[(4-chloropyridin-3-yl)amino]acetic acid manufacturers This also includes experience for drug delivery systems, efficient teams, facilities, and production capabilities. ethyl 2,3,3a,4,6,6a-hexahydro-1H-pyrrolo[2,3-c]pyrrole-5-carboxylate suppliers “We welcome a formal review into the interactions between the FDA and Biogen on the path to the approval of aducanumab,” Sandrock said. “A better understanding of the facts is good for everyone involved to assure confidence in both the therapy and the process by which it was approved as we prioritize the issues that affect patients.” 4-chloro-2-(trichloromethyl)-6-(trifluoromethyl)quinoline vendor & factory.